These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11229830)

  • 21. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
    Szabo S; Letsch R; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM
    Thromb Res; 2002 Apr; 106(2):113-9. PubMed ID: 12182909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of C1-inhibitor function by binding to type IV collagen and heparin.
    Patston PA; Schapira M
    Biochem Biophys Res Commun; 1997 Jan; 230(3):597-601. PubMed ID: 9015369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue-Type Plasminogen Activator and Tenecteplase-Mediated Increase in Blood Brain Barrier Permeability Involves Cell Intrinsic Complement.
    Keragala CB; Woodruff TM; Liu Z; Niego B; Ho H; McQuilten Z; Medcalf RL
    Front Neurol; 2020; 11():577272. PubMed ID: 33363504
    [No Abstract]   [Full Text] [Related]  

  • 25. Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI).
    Gram J; Kluft C; Jespersen J
    Thromb Haemost; 1987 Oct; 58(3):817-21. PubMed ID: 2448888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant women.
    Häggroth L; Mattsson C; Felding P; Nilsson IM
    Thromb Res; 1986 Jun; 42(5):585-94. PubMed ID: 3087015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The reaction between plasmin and C1-inhibitor results in plasmin inhibition by the serpin mechanism.
    Brown EW; Ravindran S; Patston PA
    Blood Coagul Fibrinolysis; 2002 Dec; 13(8):711-4. PubMed ID: 12441910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of recombinant tissue-type plasminogen activator (rt-PA) expressed in mouse C127 cells and human vascular plasminogen activator (HV-PA).
    Hamaguchi M; Takahashi I; Takehara T; Takamatsu J; Saito H
    Biochim Biophys Acta; 1989 Nov; 1009(2):143-50. PubMed ID: 2508748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.
    Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H
    J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition.
    Blouse GE; Perron MJ; Thompson JH; Day DE; Link CA; Shore JD
    Biochemistry; 2002 Oct; 41(40):11997-2009. PubMed ID: 12356300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clot penetration and retention by plasminogen activators promote fibrinolysis.
    Marcos-Contreras OA; Ganguly K; Yamamoto A; Shlansky-Goldberg R; Cines DB; Muzykantov VR; Murciano JC
    Biochem Pharmacol; 2013 Jan; 85(2):216-22. PubMed ID: 23098998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
    Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
    Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of human tissue plasminogen activator (t-PA) with pregnancy zone protein: a comparative study with t-PA-alpha2-macroglobulin interaction.
    Sánchez MC; Chiabrando GA; Guglielmone HA; Bonacci GR; Rabinovich GA; Vides MA
    J Biochem; 1998 Aug; 124(2):274-9. PubMed ID: 9685714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine.
    Chandler WL; Levy WC; Stratton JR
    Circulation; 1995 Nov; 92(10):2984-94. PubMed ID: 7586269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of recombinant C1 inhibitor P1 variants.
    Eldering E; Huijbregts CC; Lubbers YT; Longstaff C; Hack CE
    J Biol Chem; 1992 Apr; 267(10):7013-20. PubMed ID: 1551909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin.
    Fischer B
    Biomed Biochim Acta; 1991; 50(1):47-54. PubMed ID: 1830477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A faster-acting and more potent form of tissue plasminogen activator.
    Keyt BA; Paoni NF; Refino CJ; Berleau L; Nguyen H; Chow A; Lai J; Peña L; Pater C; Ogez J
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3670-4. PubMed ID: 8170967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assay characteristics and fibrin affinity of plasminogen activators of the intrinsic fibrinolytic system.
    Kok P; Nilsson T
    Thromb Res; 1986 Jan; 41(2):197-209. PubMed ID: 2421431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activation of plasminogen by T-PA-PAI-1 complex in the absence of fibrin.
    Takada Y; Takada A
    Thromb Res; 1991 Jul; 63(1):169-77. PubMed ID: 1835180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of papain by antithrombin due to autolytic digestion: a model of serpin inactivation of cysteine proteinases.
    Björk I; Nordling K; Raub-Segall E; Hellman U; Olson ST
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):701-9. PubMed ID: 9794814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.